USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 365.79 Thousand | 853.58 Thousand | 468 Thousand | - | - | - |
Selling, General and Administrative Expenses | 365.79 Thousand | 853.58 Thousand | 468 Thousand | - | - | - |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 365.79 Thousand | 853.58 Thousand | 468 Thousand | - | - | - |
Operating Income | -365.79 Thousand | -853.59 Thousand | -468 Thousand | - | - | - |
Interest Expense | 268.12 Thousand | 282.59 Thousand | - | - | - | - |
Income Tax Expense | -167.89 Thousand | -228.48 Thousand | -236.55 Thousand | - | - | - |
Earnings before Tax | -620.58 Thousand | -1.44 Million | -433 Thousand | - | - | - |
Net Income | -620.58 Thousand | -1.44 Million | -433 Thousand | - | - | - |
Earnings Per Share Basic | -0.00 | -0.01 | -0.00 | - | - | - |
Earnings Per Share Diluted | -0.00 | -0.01 | -0.00 | - | - | - |
Weighted Average Shares Outstanding | 173.37 Million | 114.71 Million | 380.96 Million | - | - | - |
Weighted Average Shares Outstanding (Diluted) | 173.37 Million | 114.71 Million | 380.96 Million | - | - | - |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -352.46 Thousand | -1.16 Million | -433 Thousand | - | - | - |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - |
Operating Expenses | 90.04 Thousand | 90.04 Thousand | 365.79 Thousand | 110 Thousand | 60.59 Thousand | 117.47 Thousand |
Selling, General and Administrative Expenses | 90.04 Thousand | 90.04 Thousand | - | 110 Thousand | 60.59 Thousand | 117.47 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 90.04 Thousand | 90.04 Thousand | 365.79 Thousand | 110 Thousand | 60.59 Thousand | 117.47 Thousand |
Operating Income | -90.04 Thousand | -90.04 Thousand | -365.79 Thousand | -110 Thousand | -60.59 Thousand | -117.48 Thousand |
Interest Expense | 34.96 Thousand | 32.08 Thousand | 268.12 Thousand | 51.24 Thousand | - | 105.13 Thousand |
Income Tax Expense | - | -43.27 Thousand | -167.89 Thousand | -43.81 Thousand | 39.58 Thousand | -122.08 Thousand |
Earnings before Tax | -125.01 Thousand | -123.96 Thousand | -620.58 Thousand | -142.15 Thousand | -36.54 Thousand | -276.8 Thousand |
Net Income | -125.01 Thousand | -123.96 Thousand | -620.58 Thousand | -142.15 Thousand | -36.54 Thousand | -276.8 Thousand |
Earnings Per Share Basic | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
Earnings Per Share Diluted | -0.00 | -0.00 | - | -0.00 | -0.00 | -0.00 |
Weighted Average Shares Outstanding | 993.29 Million | 648.18 Million | 173.37 Million | 484.18 Million | 142.93 Million | 125.65 Million |
Weighted Average Shares Outstanding (Diluted) | 993.29 Million | 648.18 Million | 173.37 Million | 484.18 Million | 142.93 Million | 125.65 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -90.04 Thousand | -90.04 Thousand | - | -110 Thousand | -60.59 Thousand | -117.48 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
MRSA3B
SUVENPHAR
KOAN
ALXEF
PLAZACABLE
7510